» Articles » PMID: 17130306

Effect of Tryptophan Hydroxylase 1 Deficiency on the Development of Hypoxia-induced Pulmonary Hypertension

Overview
Journal Hypertension
Date 2006 Nov 30
PMID 17130306
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Tryptophan hydroxylase 1 catalyzes the rate-limiting step in the synthesis of serotonin in the periphery. Recently, it has been shown that expression of the tryptophan hydroxylase 1 gene is increased in lungs and pulmonary endothelial cells from patients with idiopathic pulmonary arterial hypertension. Here we investigated the effect of genetic deletion of tryptophan hydroxylase 1 on hypoxia-induced pulmonary arterial hypertension in mice by measuring pulmonary hemodynamics and pulmonary vascular remodeling before and after 2 weeks of hypoxia. In wild-type mice, hypoxia increased right ventricular pressure and pulmonary vascular remodeling. These effects of hypoxia were attenuated in the tryptophan hydroxylase 1-/-mice. Hypoxia increased right ventricular hypertrophy in both wild-type and tryptophan hydroxylase 1-/-mice suggesting that in vivo peripheral serotonin has a differential effect on the pulmonary vasculature and right ventricular hypertrophy. Contractile responses to serotonin were increased in pulmonary arteries from tryptophan hydroxylase 1-/-mice. Hypoxia increased serotonin-mediated contraction in vessels from the wild-type mice, but this was not further increased by hypoxia in the tryptophan hydroxylase 1-/-mice. In conclusion, these results indicate that tryptophan hydroxylase 1 and peripheral serotonin play an essential role in the development of hypoxia-induced elevations in pulmonary pressures and hypoxia-induced pulmonary vascular remodeling. In addition, the results suggest that, in mice, serotonin has differential effects on the pulmonary vasculature and right ventricular hypertrophy.

Citing Articles

Novel Tryptophan Hydroxylase Inhibitor TPT-001 Reverses PAH, Vascular Remodeling, and Proliferative-Proinflammatory Gene Expression.

Legchenko E, Chouvarine P, Qadri F, Specker E, Nazare M, Wesolowski R JACC Basic Transl Sci. 2024; 9(7):890-902.

PMID: 39170954 PMC: 11334415. DOI: 10.1016/j.jacbts.2024.04.006.


A Review of Serotonin in the Developing Lung and Neonatal Pulmonary Hypertension.

Archambault J, Delaney C Biomedicines. 2023; 11(11).

PMID: 38002049 PMC: 10668978. DOI: 10.3390/biomedicines11113049.


Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia.

Renga G, DOnofrio F, Pariano M, Galarini R, Barola C, Stincardini C Nat Commun. 2023; 14(1):5753.

PMID: 37717018 PMC: 10505232. DOI: 10.1038/s41467-023-41536-8.


Investigation of Genes and Proteins Expression Associating Serotonin Signaling Pathway in Lung and Pulmonary Artery Tissues of Dogs with Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease: The Preliminary Study.

Tangmahakul N, Sakarin S, Techangamsuwan S, Rungsipipat A, Surachetpong S Vet Sci. 2022; 9(10).

PMID: 36288144 PMC: 9612059. DOI: 10.3390/vetsci9100530.


Serotonin-deficient neonatal mice are not protected against the development of experimental bronchopulmonary dysplasia or pulmonary hypertension.

Roberts D, Sherlock L, Posey J, Archambault J, Nozik E, Delaney C Physiol Rep. 2022; 10(19):e15482.

PMID: 36200294 PMC: 9535350. DOI: 10.14814/phy2.15482.